About IRIS International (NASDAQ:IRIS)
Mitcham Industries, Inc. is a provider of equipment to the geophysical, oceanographic and hydrographic industries. The Company operates through two segments. The Equipment Leasing segment is primarily engaged in the leasing of seismic equipment to companies in the oil and gas industry across the world. The Equipment Manufacturing and Sales segment is engaged in the design, production and sale of marine seismic equipment, and oceanographic and hydrographic equipment. Its leasing business includes Mitcham Canada ULC, Seismic Asia Pacific Pty Ltd., Mitcham Seismic Eurasia LLC, Mitcham Europe Ltd. and Mitcham Marine Leasing Pte. Ltd. The Equipment Manufacturing and Sales Segment includes its Seamap International Holdings Pte, Ltd. (Seamap) business and Klein Marine Systems, Inc. (Klein). Seamap designs, manufactures and sells a range of products for the seismic, hydrographic and offshore industries. Klein develops and manufactures high performance side scan sonar systems.
Industry, Sector and Symbol
Industry Diagnostic & Testing Substances
Sub-IndustryOil & Gas Equipment & Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-36.70%
Return on Assets-29.47%
IRIS International (NASDAQ:IRIS) Frequently Asked Questions
What is IRIS International's stock symbol?
IRIS International trades on the NASDAQ under the ticker symbol "IRIS."
How were IRIS International's earnings last quarter?
IRIS International, Inc. (NASDAQ:IRIS) released its quarterly earnings results on Wednesday, September, 7th. The scientific and technical instruments company reported ($0.80) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by $0.31. The scientific and technical instruments company earned $8.70 million during the quarter, compared to analysts' expectations of $11.20 million. IRIS International had a negative net margin of 61.58% and a negative return on equity of 36.70%. View IRIS International's Earnings History.
Who are some of IRIS International's key competitors?
Some companies that are related to IRIS International include Adaptimmune Therapeutics (ADAP), CVS Group (CVSG), PTC Therapeutics (PTCT), Cutera (CUTR), Iovance Biotherapeutics (IOVA), Reata Pharmaceuticals (RETA), Vanda Pharmaceuticals (VNDA), AngioDynamics (ANGO), LeMaitre Vascular (LMAT), Vitae Pharmaceuticals (VTAE), Universal American (UAM), TG Therapeutics (TGTX), SciClone Pharmaceuticals (SCLN), Heska (HSKA), Invacare (IVC), Collegium Pharmaceutical (COLL), Keryx Biopharmaceuticals (KERX) and Surgery Partners (SGRY).
Who are IRIS International's key executives?
IRIS International's management team includes the folowing people:
- Robert P. Capps, Co-Chief Executive Officer and Executive Vice President -Finance and Chief Financial Officer, Director
- Guy Malden, Co-Chief Executive Officer and Executive Vice President of Marine Systems
- Mark A. Cox, Vice President - Finance and Accounting, Principal Accounting Officer
- Peter H. Blum, Non-Executive Independent Chairman of the Board
- Robert John Albers, Independent Director
- Thomas S. Glanville, Independent Director
- Randal Dean Lewis, Independent Director
- Marcus C. Rowland, Independent Director
How do I buy IRIS International stock?
Shares of IRIS International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is IRIS International's stock price today?
One share of IRIS International stock can currently be purchased for approximately $8.20.
How big of a company is IRIS International?
IRIS International has a market capitalization of $350.96 million. IRIS International employs 199 workers across the globe.
How can I contact IRIS International?
IRIS International's mailing address is 9172 Eton Avenue, Chatsworth, CHATSWORTH, CA 91311-5874, United States. The scientific and technical instruments company can be reached via phone at +1-818-5277000.
MarketBeat Community Rating for IRIS International (IRIS)MarketBeat's community ratings are surveys of what our community members think about IRIS International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
IRIS International (NASDAQ:IRIS) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
IRIS International (NASDAQ:IRIS) Earnings History and Estimates Chart
IRIS International (NASDAQ IRIS) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/7/2017||Q1 2018||($0.46)||($0.24)||$12.70 million||$18.43 million||View||Listen|
|4/5/2017||Q4 2017||($0.43)||($0.83)||$13.10 million||$12.55 million||View||Listen|
|12/7/2016||Q317||($0.38)||($0.62)||$12.90 million||$8.06 million||View||N/A|
|9/7/2016||Q217||($0.49)||($0.80)||$11.20 million||$8.70 million||View||N/A|
|6/8/2016||Q117||($0.33)||($0.53)||$13.45 million||$11.70 million||View||N/A|
|4/5/2016||Q416||($0.36)||($0.63)||$12.60 million||$11.44 million||View||N/A|
|12/8/2015||Q3||($0.21)||($0.35)||$17.15 million||$15.68 million||View||N/A|
|9/2/2015||Q216||($0.25)||($0.49)||$19.50 million||$7.60 million||View||N/A|
|6/2/2015||Q116||($0.18)||($0.02)||$17.70 million||$17.14 million||View||N/A|
|4/7/2015||Q415||($0.36)||($0.32)||$14.10 million||$14.96 million||View||N/A|
|12/9/2014||Q315||$0.05||($0.03)||$22.90 million||$22.91 million||View||N/A|
|9/3/2014||Q2 15||($0.03)||($0.26)||$23.50 million||$19.55 million||View||N/A|
|6/3/2014||Q4 14||$0.31||$0.29||$27.90 million||$25.73 million||View||N/A|
|4/2/2014||Q414||$0.20||$0.14||$26.95 million||$23.60 million||View||N/A|
|12/10/2013||Q314||($0.01)||($0.14)||$21.15 million||$20.30 million||View||Listen|
|9/4/2013||Q2 2014||$0.02||$0.08||$21.15 million||$20.90 million||View||N/A|
|6/6/2013||Q2 2014||$0.49||$0.48||$29.91 million||$27.30 million||View||N/A|
|4/3/2013||Q4 2013||$0.40||$0.26||$29.10 million||$28.40 million||View||N/A|
|9/5/2012||Q213||$0.05||$0.08||$21.68 million||$23.10 million||View||N/A|
IRIS International (NASDAQ:IRIS) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for IRIS International (NASDAQ:IRIS)
No dividend announcements for this company have been tracked by MarketBeat.com
IRIS International (NASDAQ IRIS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 9.70%
Institutional Ownership Percentage: 68.94%
IRIS International (NASDAQ IRIS) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/10/2017||Thomas S Glanville||Director||Buy||10,000||$4.80||$48,000.00|| |
|4/7/2016||Midwood Capital Management Llc||Major Shareholder||Sell||178,298||$3.06||$545,591.88|| |
|9/10/2015||Midwood Capital Management Llc||Major Shareholder||Buy||50,000||$3.85||$192,500.00|| |
|9/4/2015||Midwood Capital Management Llc||Major Shareholder||Buy||7,702||$3.92||$30,191.84|| |
|8/24/2015||Midwood Capital Management Llc||Major Shareholder||Buy||6,766||$4.18||$28,281.88|| |
|8/21/2015||Midwood Capital Management Llc||Major Shareholder||Buy||15,165||$4.19||$63,541.35|| |
|8/19/2015||Midwood Capital Management Llc||Major Shareholder||Buy||2,400||$4.18||$10,032.00|| |
|7/2/2015||Peter H Blum||Director||Buy||27,451||$3.96||$108,705.96|| |
|12/22/2014||Peter H Blum||Director||Buy||15,000||$5.59||$83,850.00|| |
|12/15/2014||Peter H Blum||Director||Buy||13,037||$5.67||$73,919.79|| |
|9/15/2014||Paul Guy Rogers||VP||Sell||5,595||$11.12||$62,216.40|| |
|9/9/2014||Peter H Blum||Director||Buy||15,000||$10.45||$156,750.00|| |
|4/21/2014||John Schwalbe||Director||Sell||5,000||$13.62||$68,100.00|| |
|1/9/2014||John Schwalbe||Director||Sell||5,000||$16.81||$84,050.00|| |
|12/30/2013||Robert John Albers||Director||Sell||3,191||$17.49||$55,810.59|| |
|12/24/2013||Robert John Albers||Director||Sell||3,000||$17.34||$52,020.00|| |
|12/20/2013||Robert John Albers||Director||Sell||1,500||$16.96||$25,440.00|| |
|10/21/2013||John F Schwalbe||Director||Sell||5,000||$16.44||$82,200.00|| |
|7/25/2013||R Dean Lewis||Director||Sell||10,335||$18.02||$186,236.70|| |
|7/8/2013||John F Schwalbe||Director||Sell||5,000||$18.05||$90,250.00|| |
|4/10/2013||Paul Guy Rogers||VP||Sell||12,500||$15.00||$187,500.00|| |
|12/11/2012||Peter H Blum||Director||Buy||20,000||$11.98||$239,600.00|| |
IRIS International (NASDAQ IRIS) News Headlines
IRIS International (NASDAQ:IRIS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
IRIS International (NASDAQ:IRIS) Income Statement, Balance Sheet and Cash Flow Statement
IRIS International (NASDAQ IRIS) Stock Chart for Saturday, December, 16, 2017